1982
DOI: 10.1136/thx.37.5.324
|View full text |Cite
|
Sign up to set email alerts
|

Comparative clinical study of pulsatile and non-pulsatile perfusion in 350 consecutive patients.

Abstract: Pulsatile perfusion has been shown to offer significant haemodynamic advantages over non-pulsatile perfusion in many experimental studies. Clinical acceptance of pulsatile perfusion during cardiac surgical procedures has, however, been hampered by the lack of technologically satisfactory pulsatile pump systems, and by inadequate clinical experience of routine use of pulsatile perfusion. The recent introduction of reliable pulsatile pump systems with low haemolysis characteristics has made possible the clinical… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
42
1
2

Year Published

1988
1988
2016
2016

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(45 citation statements)
references
References 25 publications
0
42
1
2
Order By: Relevance
“…(2) and (4)] by using the real values of various arterial bifurcations. For this purpose we used the extensive dataset of diameters, lengths and distensibilities of arteries provided in Ref.…”
Section: 4 21 27mentioning
confidence: 99%
“…(2) and (4)] by using the real values of various arterial bifurcations. For this purpose we used the extensive dataset of diameters, lengths and distensibilities of arteries provided in Ref.…”
Section: 4 21 27mentioning
confidence: 99%
“…It has been long recognized that pulsatile blood flow performs the best than continuous flow because it induces both lower total peripheral resistance and mean arterial pressure (Mavroudis, 1978), and also better blood perfusion (Taylor et al, 1982). The distensibility coefficient of the vessel wall is defined as β ¼ ð2=DÞðdD=dPÞ where P is pressure within the vessel, and D is vessel diameter.…”
Section: Introductionmentioning
confidence: 99%
“…It has been easier for nurses to manage and has required no added personnel for device management -unlike ECMO support, which requires an attending perfusionist. The device provides pulsatile flow, which has been documented to improve clinical outcome (7,8), myocardial blood flow (9) and splanchnic perfusion (10), to reduce systemic vascular resistance and to attenuate catecholamine response (11). In addition, the device functions independent of cardiac rhythm and can provide support during potentially fatal arrhythmias (12,13).…”
Section: Discussionmentioning
confidence: 99%